{"pmid":32404716,"title":"A case of HIV and SARS-CoV-2 co-infection in Singapore.","text":["A case of HIV and SARS-CoV-2 co-infection in Singapore.","J Acquir Immune Defic Syndr","Louisa, Sun Jin","Lin Serene, Wong Xin","Gollamudi, Satya","32404716"],"journal":"J Acquir Immune Defic Syndr","authors":["Louisa, Sun Jin","Lin Serene, Wong Xin","Gollamudi, Satya"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404716","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1097/QAI.0000000000002401","locations":["Singapore"],"countries":["Singapore"],"countries_codes":["SGP|Singapore"],"topics":["Case Report"],"weight":1,"_version_":1666802845560602625,"score":9.490897,"similar":[{"pmid":32437000,"title":"HIV and SARS-CoV-2 co-infection: A case report from Uganda.","text":["HIV and SARS-CoV-2 co-infection: A case report from Uganda.","There are no reports of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV co-infection from sub-Saharan Africa where 70% of people living with HIV are found. We report a case of HIV/SARS-CoV-2 co-infection from Uganda. A 34 year old HIV-positive female on antiretroviral therapy (tenofovir disoproxil fumarate, lamivudine and efavirenz) for 5 years, tested positive for SARS-CoV-2, the causative agent for coronavirus disease 19 (COVID-19). She was asymptomatic at presentation but subsequently developed headache, chest pain, diarrhoea, anorexia and fatigue on day 3 of isolation without cough, fever or shortness of breath. Her CD4 count was 965 cells/mm(3) , the HIV viral load was undetectable (<1,000 cells/mm(3) ) and other laboratory work up was normal. She was successfully managed with hydroxychloroquine and broad spectrum antibiotics, and was discharged after 24 days. This case demonstrates an atypical clinical presentation of COVID - 19 in an HIV infected patient without other co-morbidity. This article is protected by copyright. All rights reserved.","J Med Virol","Baluku, Joseph Baruch","Mwebaza, Shem","Ingabire, Gloria","Nsereko, Chris","Muwanga, Moses","32437000"],"abstract":["There are no reports of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV co-infection from sub-Saharan Africa where 70% of people living with HIV are found. We report a case of HIV/SARS-CoV-2 co-infection from Uganda. A 34 year old HIV-positive female on antiretroviral therapy (tenofovir disoproxil fumarate, lamivudine and efavirenz) for 5 years, tested positive for SARS-CoV-2, the causative agent for coronavirus disease 19 (COVID-19). She was asymptomatic at presentation but subsequently developed headache, chest pain, diarrhoea, anorexia and fatigue on day 3 of isolation without cough, fever or shortness of breath. Her CD4 count was 965 cells/mm(3) , the HIV viral load was undetectable (<1,000 cells/mm(3) ) and other laboratory work up was normal. She was successfully managed with hydroxychloroquine and broad spectrum antibiotics, and was discharged after 24 days. This case demonstrates an atypical clinical presentation of COVID - 19 in an HIV infected patient without other co-morbidity. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Baluku, Joseph Baruch","Mwebaza, Shem","Ingabire, Gloria","Nsereko, Chris","Muwanga, Moses"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437000","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26044","keywords":["covid-19","hiv","sars-cov-2","uganda"],"locations":["Uganda","Uganda"],"countries":["Uganda"],"countries_codes":["UGA|Uganda"],"e_drugs":["Tenofovir","Hydroxychloroquine","efavirenz","Lamivudine"],"topics":["Case Report"],"weight":1,"_version_":1667521393570349056,"score":48.69883},{"pmid":32347975,"title":"HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.","text":["HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.","In December 2019, the causative agent of Coronavirus disease 2019 (COVID-19) was identified and named as SARS-CoV-2. Since then it has been spreading and severe form of the illness predominantly occurs in adults with advanced age or underlying comorbidities. The European AIDS Clinical Society states the lack of evidence for a higher COVID-19 infection rate among people living with HIV (PLHIV) and there is a few published literature on the course of COVID-19 co-infection in PLHIV. We described four HIV/SARS-CoV-2 co-infected patients with different characteristics. The impression is that comorbidities is an important factor in mortality in HIV/SARS-CoV-2 co-infected cases. This article is protected by copyright. All rights reserved.","J Med Virol","Altuntas Aydin, Ozlem","Kumbasar Karaosmanoglu, Hayat","Kart Yasar, Kadriye","32347975"],"abstract":["In December 2019, the causative agent of Coronavirus disease 2019 (COVID-19) was identified and named as SARS-CoV-2. Since then it has been spreading and severe form of the illness predominantly occurs in adults with advanced age or underlying comorbidities. The European AIDS Clinical Society states the lack of evidence for a higher COVID-19 infection rate among people living with HIV (PLHIV) and there is a few published literature on the course of COVID-19 co-infection in PLHIV. We described four HIV/SARS-CoV-2 co-infected patients with different characteristics. The impression is that comorbidities is an important factor in mortality in HIV/SARS-CoV-2 co-infected cases. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Altuntas Aydin, Ozlem","Kumbasar Karaosmanoglu, Hayat","Kart Yasar, Kadriye"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347975","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/jmv.25955","keywords":["hiv","sars-cov-2","co-infection"],"locations":["Istanbul","Turkey"],"countries":["Turkey"],"countries_codes":["TUR|Turkey"],"topics":["Case Report"],"weight":1,"_version_":1666138494930518016,"score":44.663696},{"pmid":32427361,"title":"4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York.","text":["4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York.","Originating from Wuhan, China, the novel coronavirus 2019 (SARS-CoV-2) has been spreading worldwide since the end of 2019. The most common features of these patients include fever, cough, myalgia or fatigue [1]. As of April 16, 2020 the CDC has reported 605,390 cases and 24,582 deaths in the United States. The illness continues to spread through the world infecting people with various different comorbid conditions. Presented here are four cases which represent some of the first cases of HIV and SARS-CoV-2 coinfection in Long Island, New York. These HIV infected patients were compliant with their HIV medication regimen and had robust CD4 T cell counts. The clinical severity ranged from mild to requiring hospitalization. Three of the four patients had fever and two had cough. One patient presented with diarrhea, the incidence rate of diarrhea in SARS-CoV-2 infection range from 2% to 50% of cases [4]. One patient had anosmia and aguesia, in a study by Moein et al, the 98% of SARS-CoV-2 infected patient experienced some smell dysfunction [5]. One patient required hospitalization however this patient was also infected with influenza A. These cases suggest that uncomplicated cases of SARS-CoV-2 in an HIV infected patient can be managed with self-isolation at home. This article is protected by copyright. All rights reserved.","J Med Virol","Benkovic, Scott","Kim, Michelle","Sin, Eric","32427361"],"abstract":["Originating from Wuhan, China, the novel coronavirus 2019 (SARS-CoV-2) has been spreading worldwide since the end of 2019. The most common features of these patients include fever, cough, myalgia or fatigue [1]. As of April 16, 2020 the CDC has reported 605,390 cases and 24,582 deaths in the United States. The illness continues to spread through the world infecting people with various different comorbid conditions. Presented here are four cases which represent some of the first cases of HIV and SARS-CoV-2 coinfection in Long Island, New York. These HIV infected patients were compliant with their HIV medication regimen and had robust CD4 T cell counts. The clinical severity ranged from mild to requiring hospitalization. Three of the four patients had fever and two had cough. One patient presented with diarrhea, the incidence rate of diarrhea in SARS-CoV-2 infection range from 2% to 50% of cases [4]. One patient had anosmia and aguesia, in a study by Moein et al, the 98% of SARS-CoV-2 infected patient experienced some smell dysfunction [5]. One patient required hospitalization however this patient was also infected with influenza A. These cases suggest that uncomplicated cases of SARS-CoV-2 in an HIV infected patient can be managed with self-isolation at home. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Benkovic, Scott","Kim, Michelle","Sin, Eric"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427361","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26029","keywords":["coronavirus","human immunodeficiency virus","influenza virus","pandemics"],"locations":["Wuhan","China","myalgia","fatigue","United States","Long Island","New York","Long Island","New York"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1667352728870846466,"score":44.055897},{"pmid":32160316,"title":"Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.","text":["Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.","J Med Virol","Zhu, Feng","Cao, Yang","Xu, Shuyun","Zhou, Min","32160316"],"journal":"J Med Virol","authors":["Zhu, Feng","Cao, Yang","Xu, Shuyun","Zhou, Min"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32160316","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.1002/jmv.25732","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138492666642434,"score":43.159935}]}